Co-Founder and Co-Chief Executive Officer of Parallel Bio, building human immune system organoids to replace animal testing in drug development. Before founding Parallel Bio in 2021, served as Director of Strategy and Research Development at Stanford University School of Medicine’s Institute for Immunity, Transplantation, and Infection, overseeing a $100 million scientific portfolio and managing eight large- scale research and development programmes. Work in global health includes leading vaccine programmes in partnership with GSK, the National Institutes of Health and the Danish government. Completed postdoctoral training at Stanford, holds a PhD in immunology from the University of Pittsburgh and a BS from the University of Illinois at Urbana-Champaign.
